Z-0926-2021 Class II Terminated

Recalled by Medtronic Inc., Cardiac Rhythm And Heart Failure (CRHF) — Mounds View, MN

FDA device recall Z-0926-2021 was initiated by Medtronic Inc., Cardiac Rhythm And Heart Failure (CRHF) on Nov 15, 2020 and is designated Class II. Reason for recall: Under rare circumstances, the component may be susceptible to a failure mechanism that could impact device performance, including potential loss of function. The recall status is terminated (terminated Dec 23, 2025). Affected quantity: 2 units.

Recall details

Product Type
Devices
Report Date
Feb 3, 2021
Initiation Date
Nov 15, 2020
Termination Date
Dec 23, 2025
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
2 units

Product description

Medtronic COBALT HF QUAD CRT-D MRI SureScan, Model Number DTPB2QQ, MR Conditional implantable cardioverter defibrillator with cardiac resynchronization therapy, SureScan technology, and Bluetooth wireless telemetry (DDE-DDDR)

Reason for recall

Under rare circumstances, the component may be susceptible to a failure mechanism that could impact device performance, including potential loss of function.

Distribution pattern

Distribution to US states of GA, PA, NJ, and France

Code information

Serial Numbers: RTK602501S, RTK602506S

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-0926-2021
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-0926-2021. Report a data issue: hello@regdatalab.com.